By CHAD BRAY
The $40.5 billion transaction would be the latest in what has been a frenzied period of deal-making in the pharmaceutical sector.
Published: July 28, 2015 at 12:00AM
Read more at: NYT Business Day
By CHAD BRAY
The $40.5 billion transaction would be the latest in what has been a frenzied period of deal-making in the pharmaceutical sector.
Published: July 28, 2015 at 12:00AM
Read more at: NYT Business Day